Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Bernstein

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
How does auranofin compare with methotrexate and cyclosporin as a corticosteroid-sparing agent in severe asthma?I L Bernstein, D I Bernstein, J A Bernstein
Chest|March 1, 1991
Potentially fatal asthma and syncope. A new variant of Munchausen's syndrome in sports medicineJ A Bernstein, M S Dykewicz, P Histand, et al.
The Journal of Allergy and Clinical Immunology|September 2, 1998
Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthmaZ L Lummus, R Alam, J A Bernstein, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1994
A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary aminesJ A Bernstein, T Stauder, D I Bernstein, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 1, 1997
Prevalence of human seminal plasma hypersensitivity among symptomatic womenJ A Bernstein, R Sugumaran, D I Bernstein, et al.
Toxicology|July 17, 1996
Characterization of histamine releasing factors in diisocyanate-induced occupational asthmaZ L Lummus, R Alam, J A Bernstein, et al.
Annals of Allergy|November 1, 1994
Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxisJ A Bernstein, S L Kagen, D I Bernstein, et al.
Archives of Environmental Health|January 5, 2002
Are high-dose toxic exposures always associated with reactive airways dysfunction syndrome (RADS)?M A Hickmann, E D Nelson, E G Siegel, et al.
The Journal of Allergy and Clinical Immunology|February 1, 1997
T-cell receptor V beta gene segment expression in diisocyanate-induced occupational asthmaJ A Bernstein, J Munson, Z L Lummus, et al.
Indoor Air|November 5, 2005
A pilot study to investigate the effects of combined dehumidification and HEPA filtration on dew point and airborne mold spore counts in day care centersJ A Bernstein, L Levin, M S Crandall, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
How does auranofin compare with methotrexate and cyclosporin as a corticosteroid-sparing agent in severe asthma?I L Bernstein, D I Bernstein, J A Bernstein
Chest|March 1, 1991
Potentially fatal asthma and syncope. A new variant of Munchausen's syndrome in sports medicineJ A Bernstein, M S Dykewicz, P Histand, et al.
The Journal of Allergy and Clinical Immunology|September 2, 1998
Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthmaZ L Lummus, R Alam, J A Bernstein, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1994
A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary aminesJ A Bernstein, T Stauder, D I Bernstein, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 1, 1997
Prevalence of human seminal plasma hypersensitivity among symptomatic womenJ A Bernstein, R Sugumaran, D I Bernstein, et al.
Toxicology|July 17, 1996
Characterization of histamine releasing factors in diisocyanate-induced occupational asthmaZ L Lummus, R Alam, J A Bernstein, et al.
Annals of Allergy|November 1, 1994
Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxisJ A Bernstein, S L Kagen, D I Bernstein, et al.
Archives of Environmental Health|January 5, 2002
Are high-dose toxic exposures always associated with reactive airways dysfunction syndrome (RADS)?M A Hickmann, E D Nelson, E G Siegel, et al.
The Journal of Allergy and Clinical Immunology|February 1, 1997
T-cell receptor V beta gene segment expression in diisocyanate-induced occupational asthmaJ A Bernstein, J Munson, Z L Lummus, et al.
Indoor Air|November 5, 2005
A pilot study to investigate the effects of combined dehumidification and HEPA filtration on dew point and airborne mold spore counts in day care centersJ A Bernstein, L Levin, M S Crandall, et al.
Pageof 6